Anyone over the age of 50 in Britain will be offered a third COVID-19 vaccine in the fall with the aim of eradicating the threat of infection entirely by Christmas, The newspaper reported. Times.
Trials of two options are underway, overseen by Chris Whitty, England’s chief medical officer, the newspaper said.
The first concerns vaccines specifically modified to tackle new variants. The second is for a third plan of one of the three versions already in use: Pfizer-BioNTech (PFE.N), (22UAy.DE), Oxford-AstraZeneca (AZN.L) or Moderna (MRNA.O), the journal reported.
In total, more than 34.6 million people in Britain have received a first dose of the COVID-19 vaccine, according to government statistics on Tuesday.
Britain, with a population of 67 million, has reached deals for more than 510 million doses of eight different COVID-19 vaccines, some of which are still in development. Read more
Britain will buy an additional 60 million doses of Pfizer / BioNTech vaccine, Health Minister Matt Hancock said last week, as part of a deal that more than doubles the country’s vaccine supply before a recall program later this year.
Britain has now ordered a total of 100 million doses of the Pfizer vaccine, one of three COVID-19 vaccines being deployed in the country.
Our Standards: Thomson Reuters Trust Principles.